Chronic Rhinosinusitis with Nasal Polyps: Bench to Bedside and Beyond
Price: FREE for members and non-members
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a type 2 inflammatory disorder that has direct effects on quality of life, comorbid conditions, and healthcare costs. Join our experts to learn more about this disorder, diagnosis and recent developments in treating it.
Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.
1. Describe the epidemiology of chronic rhinosinusitis with nasal polyps and its association with other disease states
2. Discuss the underlying pathophysiology of chronic rhinosinusitis with nasal polyps; endotypes and phenotypes.
3. Examine the advantages and disadvantages of the conventional and new FDA approved treatments for chronic rhinosinusitis with nasal polyps
Anjeni Keswani, MD, MSCI, Assistant Professor of Medicine, George Washington University
Whitney Stevens, MD, PhD, Assistant Professor of Medicine, Northwestern University
Seong Cho, MD, Associate Professor, Medicine & Pediatrics, University of South Florida